References
- Van Der Weide M., Sizoo W., Nauta J. J., Krefft J., Langenhuijsen M. M.A.C. Myelodysplastic syndromes: analysis of clinical and prognostic features in ninety six patients. European Journal of Haematology 1988; 41: 58–61
- Rummens J. L., Verfaillie C., Criel A., Hidajat M., Van-Hoof A., Van Den Berghe H., Louwagie A. Elliptocytosis and schistocytosis in myelodysplasia: report of two cases. Acta Haematologica 1986; 75: 174–177
- Hartz J. W., Buss D. H., White D. R., Bond M. G., Senary M. Marked elliptocytosis and schistocytosis in hematopoietic dysplasia. American Journal of Clinical Pathology 1984; 82: 354–359
- Green A. R., Shuttleworth D., Bowen D. T., Bentley D. P. Cutaneous vasculitis in patients with myelodysplasia. British Journal of Haematology 1990; 74: 364–365
- Savige J. A., Chang L., Smith C. L., Duggan J. C. Myelodysplasia, vasculitis and anti-neutrophil antibodies. Leukaemia and Lymphoma 1993; 9: 49–54
- Billstrom R., Johansson H., Johansson B., Mittleman F. Immune mediated complications in patients with myelodysplastic syndromes - clinical and cytogenetic features. European Journal of Haematology 1995; 55: 42–48
- Enright H., Jacob H. S., Vercollotti G., Howe R., Belzer M., Miller W. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. British Journal of Haematology 1995; 91: 403–408